companydata.dkcompanydata.dk

Mammen BioProcess Support ApS: Financial statements 2025

CVR: 43983881

Source: annual report 2025, Danish Business Authority

01/04/2024 – 31/03/2025

Mammen BioProcess Support ApS (CVR 43983881) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,500,623 and a net result of DKK 261,391 compared with DKK 436,464 the year before. That is a decrease of 8.3% compared with the year before. Equity in the 2025 report amounted to DKK 307,855. The solvency ratio was 39.5%.

Gross Profit
DKK 1,500,623
Profit/Loss
DKK 261,391
Equity
DKK 307,855
Total Assets
DKK 779,332
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-1.5M261K308K0
2024-1.6M436K476K1

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Mammen BioProcess Support ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

About Mammen BioProcess Support ApS

Mammen BioProcess Support ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2023. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for byggeri og anlægsarbejder. The management consists of Max Løjtved Mammen. The company is owned by Max Mammen Holding ApS. The company has 1 employee (2026). In 2026, the company reported a gross profit of DKK 1,787,690 and a net result of DKK 362,902 compared with DKK 261,391 the year before. Equity in the 2026 report amounted to DKK 670,757.

Source: annual report 2026, Danish Business Authority

Other financial years